Journal of Affective Disorders, Год журнала: 2022, Номер 317, С. 156 - 165
Опубликована: Авг. 26, 2022
Язык: Английский
Journal of Affective Disorders, Год журнала: 2022, Номер 317, С. 156 - 165
Опубликована: Авг. 26, 2022
Язык: Английский
Brain Research Bulletin, Год журнала: 2022, Номер 182, С. 44 - 56
Опубликована: Фев. 11, 2022
Depression is the most common mental disorder and a leading cause of disability worldwide. Despite abundant research, precise mechanisms underlying pathophysiology depression remain elusive. Accumulating evidence from preclinical clinical studies suggests that alterations in gut microbiota, microbe-derived short-chain fatty acids, D-amino acids metabolites play key role via brain–gut–microbiota axis, including neural immune systems. Notably, axis might crucial susceptibility versus resilience rodents exposed to stress. Vagotomy reported block depression-like phenotypes after fecal microbiota transplantation "depression-related" microbiome, suggesting vagus nerve influences through axis. In this article, we review recent findings regarding discuss its potential as therapeutic target for depression.
Язык: Английский
Процитировано
244Brain Research Bulletin, Год журнала: 2022, Номер 182, С. 130 - 140
Опубликована: Фев. 12, 2022
The spleen, an important tissue for the immune system, acts as a filter blood within system. Accumulating evidence suggests that spleen affects number of brain functions in health and diseases via modulation. Systemic inflammation or chronic social defeat stress (CSDS) can cause splenomegaly rodents. Interestingly, new antidepressant arketamine could normalize depression-like behaviors CSDS-susceptible mice. A recent study strongly supports direct connection pathway between whereby regulate humoral defense by two regions, such corticotropin-related neurons paraventricular nucleus (PVN) central amygdala (CeA). Furthermore, afferent efferent vagus nerve signaling may contribute to communication. In this article, we review findings brain-spleen axis diseases.
Язык: Английский
Процитировано
88Molecular Psychiatry, Год журнала: 2023, Номер 28(9), С. 3625 - 3637
Опубликована: Сен. 1, 2023
Abstract The human body harbors a diverse ecosystem of microorganisms, including bacteria, viruses, and fungi, collectively known as the microbiota. Current research is increasingly focusing on potential association between microbiota various neuropsychiatric disorders. resides in parts body, such oral cavity, nasal passages, lungs, gut, skin, bladder, vagina. gut gastrointestinal tract has received particular attention due to its high abundance role psychiatric neurodegenerative However, presents other tissues, though less abundant, also plays crucial immune system homeostasis, thus influencing development progression For example, imbalance associated periodontitis might increase risk for Additionally, studies using postmortem brain samples have detected widespread presence bacteria brains patients with Alzheimer’s disease. This article provides an overview emerging host disorders discusses future directions, underlying biological mechanisms, reliable biomarkers microbiota, microbiota-targeted interventions, this field.
Язык: Английский
Процитировано
51Pharmaceuticals, Год журнала: 2023, Номер 16(4), С. 565 - 565
Опубликована: Апрель 9, 2023
The gut microbiota is critical for maintaining human health and the immunological system. Several neuroscientific studies have shown significance of in developing brain systems. are interconnected a bidirectional relationship, as research on microbiome–gut–brain axis shows. Significant evidence links anxiety depression disorders to community microbes that live gastrointestinal Modified diet, fish omega-3 fatty acid intake, macro- micro-nutrient prebiotics, probiotics, synbiotics, postbiotics, fecal transplantation, 5-HTP regulation may all be utilized alter treatment approach. There few preclinical clinical effectiveness reliability various therapeutic approaches anxiety. This article highlights relevant association with different possibilities modification.
Язык: Английский
Процитировано
48Food Research International, Год журнала: 2024, Номер 182, С. 114153 - 114153
Опубликована: Фев. 23, 2024
Язык: Английский
Процитировано
17Translational Psychiatry, Год журнала: 2021, Номер 11(1)
Опубликована: Ноя. 8, 2021
Abstract Major depressive disorder (MDD) is a serious mental illness. Increasing evidence from both animal and human studies suggested that the gut microbiota might be involved in onset of depression via gut–brain axis. However, mechanism remains unclear. To explore protein changes axis modulated by microbiota, germ-free mice were transplanted with MDD patients to induce depression-like behaviors. Behavioral tests performed following fecal transplantation. A quantitative proteomics approach was used examine expression prefrontal cortex (PFC), liver, cecum, serum. Then differential analysis weighted gene coexpression network identify microbiota-related modules. Our results induced alteration levels multiple tissues phenotype, these PFC liver model specific compared chronic stress models. Gene ontology enrichment revealed variety biological functions, including metabolic process inflammatory response, which energy metabolism core change network. data provide clues for future on level deepen understanding how cause
Язык: Английский
Процитировано
71Nutrients, Год журнала: 2022, Номер 14(14), С. 2945 - 2945
Опубликована: Июль 19, 2022
Evidence linking Faecalibacterium prausnitzii abundance to nonalcoholic fatty liver disease (NAFLD) is accumulating; however, the causal relationship remains obscure. In this study, 12 F. strains were orally administered high fat diet fed C57BL/6J mice for weeks evaluate protective effects of on NAFLD. We found that five strains, A2-165, LB8, ZF21, PL45, and LC49, significantly restored serum lipid profiles ameliorated glucose intolerance, adipose tissue dysfunction, hepatic steatosis, inflammation, oxidative stress in a mouse model Moreover, two LC49 enhanced short-chain acid (SCFA) production modulated gut microbiota. Based combined analysis linear discriminant effect size microbial communities, core microbiome related NAFLD comprised Odoribacter, Roseburia, Erysipelatoclostridium, Tyzzerella, Faecalibaculum, Blautia, Acetatifactor, last genera can be reversed by treatment with LB8 strains. Additionally, enriched Lactobacillus, Ileibacterium, Faecalibacterium, Dubosiella, Bifidobacterium downregulated pathways involving carbohydrate metabolism, amino biosynthesis. Interestingly, supplementation also upregulated tryptophan glutathione valine, leucine, isoleucine degradation, which might prevention. Collectively, exerted considerable anti-NAFLD microbiota-regulating effects, indicating their potential as probiotic agents treatment.
Язык: Английский
Процитировано
57Frontiers in Neurology, Год журнала: 2022, Номер 13
Опубликована: Ноя. 10, 2022
Depression is a worldwide disease causing severe disability, morbidity, and mortality. Despite abundant studies, the precise mechanisms underlying pathophysiology of depression remain elusive. Recently, cumulate research suggests that disturbance microbiota-gut-brain axis may play vital role in etiology while correcting this could alleviate symptoms. The vagus nerve, linking brain gut through its afferent efferent branches, critical route bidirectional communication axis. Directly or indirectly, fibers can sense relay microbiota signals to induce disorders including depression. Also, changes response stress result hyperpermeability inflammation mediating by vagal efferents, which be detrimental Notably, nerve stimulation owns an anti-inflammatory effect was proved for treatment. Nevertheless, accompanied low tone, derive from contribute pathogenesis In review, we aim explore perspective axis, highlighting relationship among hyperpermeability, inflammation,
Язык: Английский
Процитировано
55Neurobiology of Disease, Год журнала: 2022, Номер 165, С. 105635 - 105635
Опубликована: Янв. 24, 2022
Multiple sclerosis (MS) is the most common demyelinating disease that attacks central nervous system. We recently reported new antidepressant (R)-ketamine could ameliorate progression in experimental autoimmune encephalomyelitis model of MS. Cuprizone (CPZ) has been used to produce demyelination which resembles MS patients. This study was undertaken investigate whether affect CPZ-treated mice and remyelination after CPZ withdrawal. Repeated treatment with (10 mg/kg/day, twice weekly, for 6 weeks) significantly ameliorated activated microglia brain compared saline-treated mice. Furthermore, pretreatment ANA-12 (TrkB antagonist) blocked beneficial effects on The 16S rRNA analysis showed improved abnormal composition gut-microbiota decreased levels lactic acid In addition, there were significant correlations between (or microglial activation) relative abundance several microbiome, suggesting a link gut microbiota brain. Interestingly, facilitate conclusion, suggests through TrkB activation, gut-microbiota-microglia crosstalk may play role Therefore, it likely be therapeutic drug
Язык: Английский
Процитировано
52Life, Год журнала: 2022, Номер 12(2), С. 196 - 196
Опубликована: Янв. 28, 2022
Major depressive disorder is one of the most prevalent mental health disorders. Monoamine-based antidepressants were first drugs developed to treat major disorder. More recently, ketamine and other analogues introduced as fast-acting antidepressants. Unfortunately, currently available therapeutics are inadequate; lack efficacy, adverse effects, risks leave patients with limited treatment options. Efforts now focused on understanding etiology depression identifying novel targets for pharmacological treatment. In this review, we discuss promising Targeting receptors including N-methyl-D-aspartate receptors, peroxisome proliferator-activated G-protein-coupled receptor 39, metabotropic glutamate galanin opioid has potential antidepressant effects. Compounds targeting biological processes: inflammation, hypothalamic-pituitary-adrenal axis, cholesterol biosynthesis pathway, gut microbiota have also shown therapeutic potential. Additionally, natural products plants, herbs, fatty acids improved symptoms behaviors. a brief history clinically will be provided, primary focus pharmaceutical approaches effects in preclinical clinical studies.
Язык: Английский
Процитировано
48